Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Victoza
Pharma
Novo asks FDA to restrict compounding of legacy GLP-1 Victoza
Amid a broader campaign to snuff out compounded semaglutide, Novo Nordisk is shifting its outsourcing concerns to its legacy GLP-1 Victoza.
Fraiser Kansteiner
Jan 3, 2025 3:25pm
Shortages of Novo Nordisk's Ozempic to persist into Q4
Sep 3, 2024 11:14am
Oprah shines her star power on weight loss drugs in TV special
Mar 19, 2024 11:57am
Novo Nordisk to reduce supply of Victoza to make more Ozempic
Nov 22, 2023 10:55am
The top 10 drug patent expirations of 2023
Mar 13, 2023 3:00am
Novo Nordisk and Novartis ink Victoza generics pact
Mar 23, 2022 9:55am
